A new publication referencing MOTS-c was published on August 10, 2026. The article, titled "Emerging regulators of human physiology and disease; sORF-encoded microproteins," appeared in the journal Epigenomics. MOTS-c remains classified as an unapproved research compound. This publication is indexed under PubMed ID 42576277 and can be accessed through the linked PubMed record. No specific findings, data, or conclusions from the publication are detailed here beyond its title and place of publication. The listing reflects that this work has entered the scientific literature and is now available for review by researchers and other interested parties. As with all research publications, readers seeking to understand the content, methodology, or conclusions of the study should consult the original source directly. This brief does not characterize or summarize any results, mechanisms, or implications discussed in the paper. It serves only to note the existence and placement of this new entry in the peer reviewed literature concerning sORF-encoded microproteins, a category that includes MOTS-c. For additional background on MOTS-c, readers can refer to the compound overview.
New Publication on MOTS-c Appears in Epigenomics Journal
Source: https://pubmed.ncbi.nlm.nih.gov/42576277/